Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments and Licenses - Equity Method Investments Narrative (Details)

v3.7.0.1
Acquisitions, Investments and Licenses - Equity Method Investments Narrative (Details)
$ in Millions
3 Months Ended
Mar. 31, 2017
USD ($)
Schedule of Equity Method Investments [Line Items]  
Total assets of equity method investees $ 412.7
Total (liabilities) of equity method investees 201.5
Net (losses) of equity method investees (59.5)
Market value $ 37.8
Pharmsynthez  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 9.00%
Cocrystal  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 8.00%
Sevion  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 3.00%
Non-Invasive Monitoring Systems, Inc.  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 1.00%
Neovasc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 4.00%
VBI Vaccines Inc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 15.00%
InCellDx, Inc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 27.00%
BioCardia, Inc.  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 5.00%